Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis
Qiuxing He, Yanting You, Lin Yu, et al.
Psychiatry Research (2020) Vol. 292, pp. 113305-113305
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
Nataša R. Mijailović, Katarina Vesić, Milica Borovčanin
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 54
Why Does Hyperuricemia Not Necessarily Induce Gout?
Wei‐Zheng Zhang
Biomolecules (2021) Vol. 11, Iss. 2, pp. 280-280
Open Access | Times Cited: 53
Variants in urate transporters, ADH1B, GCKR and MEPE genes associate with transition from asymptomatic hyperuricaemia to gout: results of the first gout versus asymptomatic hyperuricaemia GWAS in Caucasians using data from the UK Biobank
Gabriela Sandoval‐Plata, Kevin Morgan, Abhishek Abhishek
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 9, pp. 1220-1226
Open Access | Times Cited: 45
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
Samskruthi Madireddy, Sahithi Madireddy
Brain Sciences (2020) Vol. 10, Iss. 10, pp. 742-742
Open Access | Times Cited: 40
Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players
Juan D. Molina, Sonia Avila, Gabriel Rubio, et al.
Current Pharmaceutical Design (2021) Vol. 27, Iss. 39, pp. 4049-4061
Open Access | Times Cited: 28
Uric acid en route to gout
Wei‐Zheng Zhang
Advances in clinical chemistry (2023), pp. 209-275
Closed Access | Times Cited: 12
Physical, Psychiatric, and Social Comorbidities of Individuals with Schizophrenia Living in the Community in Japan
Masaaki Matsunaga, Yuanying Li, Yupeng He, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 4336-4336
Open Access | Times Cited: 11
Salivary Metabolomics Reveals that Metabolic Alterations Precede the Onset of Schizophrenia
Gaoping Cui, Ying Qing, Minghui Li, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 11, pp. 5010-5023
Closed Access | Times Cited: 26
Blood and Urinary Biomarkers of Antipsychotic-Induced Metabolic Syndrome
Aiperi K. Khasanova, В. С. Добродеева, N. А. Shnayder, et al.
Metabolites (2022) Vol. 12, Iss. 8, pp. 726-726
Open Access | Times Cited: 16
Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury
Sheng Wang, Liyun Zhang, Dongsheng Hao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Positive Effects of Uric Acid on White Matter Microstructures and Treatment Response in Patients With Schizophrenia
Minji Bang, Yul Heo, Tai Kiu Choi, et al.
Schizophrenia Bulletin (2024) Vol. 50, Iss. 4, pp. 815-826
Closed Access | Times Cited: 3
Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
Milica Borovčanin, Slavica Minic Janicijevic, Nataša R. Mijailović, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 13
Comparison of Hematological Parameters Between First-Episode Schizophrenia and Anti-NMDAR Encephalitis
Kai Huang, Yamei Tang, Zhiheng Chen, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 10
Schizophrenia and Alarmins
Huan Ma, Ning Cheng, Caiyi Zhang
Medicina (2022) Vol. 58, Iss. 6, pp. 694-694
Open Access | Times Cited: 9
Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese
Qi Zhang, Hui He, Xia Bai, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 12
Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period
Zelin Yuan, Huamin Liu, Xiaochun Zhang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 4
Associations of C-Reactive Protein, Free Triiodothyronine, Thyroid Stimulating Hormone and Creatinine Levels with Agitation in Patients with Schizophrenia: A Comparative Cross-Sectional Study
Chao Li, Zhenchun Shi, Jiacui Ji, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2575-2585
Open Access | Times Cited: 10
Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study
Hualin Cai, Cuirong Zeng, Xiangyang Zhang, et al.
Psychiatry Research (2022) Vol. 316, pp. 114762-114762
Closed Access | Times Cited: 7
The relationship between uric acid levels, cognition and inflammation in a cohort of elderly subjects
Burak Subaşı, Erman Esnafoğlu
Journal of Neural Transmission (2024) Vol. 131, Iss. 9, pp. 1059-1065
Closed Access | Times Cited: 1
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
Abdul‐rizaq Hamoud, Karen Bach, Ojal Kakrecha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11835-11835
Open Access | Times Cited: 6
Post-weaning social isolation impairs purinergic signaling in rat brain
Roberta Andrejew, Milla Paim, César Eduardo Jacintho Moritz, et al.
Neurochemistry International (2021) Vol. 148, pp. 105111-105111
Closed Access | Times Cited: 5
Reduced levels of plasma strong antioxidant uric acid in children with Autism Spectrum Disorder and Attention deficit-hyperactivity disorder
Erman Esnafoğlu, Emine Yurdakul Ertürk
MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE (2023) Vol. 9, Iss. 2, pp. 351-361
Open Access | Times Cited: 1
Evaluation of serum natural antioxidant levels in patients with schizophrenia, schizoaffective disorder, and bipolar disorder
Derya Canlı, Aslıhan Dilara Demir
Deleted Journal (2024) Vol. 3, Iss. 2, pp. 41-45
Open Access
Prevalence, demographic characteristics, and clinical features of suicide risk in first episode drug-naïve schizophrenia patients with comorbid severe anxiety
Mengjie Ding, Xiaoe Lang, Junhan Wang, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 232-239
Closed Access
The relationship of serum uric acid, serum uric acid creatinine ratios with disease severity and metabolic syndrome in schizophrenia patients
Merve Akkuş, Kader Semra Karataş, Onur Gökçen, et al.
Acta Medica Alanya (2024) Vol. 8, Iss. 2, pp. 122-128
Open Access
Page 1 - Next Page

Scroll to top